Our study suggested that increased IL-10 expression of TAM in NSCLC patients correlated with late stage disease (stage II, III and IV), lymph node metastases, pleural invasion, lymphovascular invasion and poor differentiation. The gene discussed is IL10; the disease is metastatic malignant neoplasm in the lymph nodes.